[1]
D. A. Feldman, “Asymmetric dimethylarginine – a marker of repeated cardiovascular events in patients with comorbid pathology”, Rep. of Vinnytsia Nation. Med. Univ., vol. 25, no. 4, pp. 567-571, Nov. 2021.